December 6, 2024
Willkie advised Venrock on the formation of Venrock Healthcare Capital Partners XP, L.P. (VHCP XP) at $500 million.
On November 19, 2024, Venrock Healthcare Capital Partners raised $500 million for VHCP XP, successfully reaching its fundraising cap in a single closing with strong support from existing investors.
Venrock Healthcare Capital Partners focuses on long-term investment opportunities in small capitalization public companies and late-stage private companies across the healthcare and life sciences industry, with an emphasis on biopharmaceuticals.
The Willkie team was led by partner David Hong and included partners Justin Browder and Russell Pinilis and associates Edward Kocis, Jakob Edson and Freddie Alvarado.
On November 19, 2024, Venrock Healthcare Capital Partners raised $500 million for VHCP XP, successfully reaching its fundraising cap in a single closing with strong support from existing investors.
Venrock Healthcare Capital Partners focuses on long-term investment opportunities in small capitalization public companies and late-stage private companies across the healthcare and life sciences industry, with an emphasis on biopharmaceuticals.
The Willkie team was led by partner David Hong and included partners Justin Browder and Russell Pinilis and associates Edward Kocis, Jakob Edson and Freddie Alvarado.
